Skip to content
MedsAcross

Brand family

Alymsys

Bevacizumab · Amneal Pharmaceuticals
United States
Presentations
2
Markets
1

Alymsys is a brand of Bevacizumab marketed by Amneal Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Bevacizumab
Brand owner
Amneal Pharmaceuticals
Registered in
United States
Strengths and forms
100 mg/4 mL injection, 400 mg/16 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Alymsys 100 mg/4 mL injectionIntravenous Cold chainAmneal PharmaceuticalsUS FDAAvailable on request
Alymsys 400 mg/16 mL injectionIntravenous Cold chainAmneal PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Bevacizumab.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Alymsys

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.